Expression of Yes-associated protein (YAP) in metastatic breast cancer

Hye Min Kim, Woo Hee Jung, Ja Seung Koo

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

The purpose of this study was to investigate the expression of Yes-associated protein (YAP) in different metastatic sites in metastatic breast cancer and to determine the clinical implications of these patterns. Immunohistochemical staining was used to investigate the expression of YAP and phospho-YAP in tissue microarrays from 122 cases of metastatic breast cancer (bone metastasis = 29, brain metastasis = 38, liver metastasis = 12, and lung metastasis = 43). The expression levels of YAP and phospho-YAP differed according to the metastatic site in metastatic breast cancer. Specifically, nuclear expression of phospho-YAP was high in brain metastasis but low in lung metastasis (P = 0.010). The effects of YAP and phospho-YAP expression on clinical outcomes were investigated by univariate analysis. This analysis showed that nuclear YAP positivity (P = 0.008) and nuclear phospho-YAP positivity (P = 0.003) were both associated with shorter overall survival. In conclusion, the level of YAP expression varies according to the metastatic site in metastatic breast cancer. Moreover, high YAP expression was correlated with poor prognosis.

Original languageEnglish
Pages (from-to)11248-11257
Number of pages10
JournalInternational Journal of Clinical and Experimental Pathology
Volume8
Issue number9
Publication statusPublished - 2015 Jan 1

Fingerprint

Breast Neoplasms
Proteins
Neoplasm Metastasis
Bone Neoplasms
Lung
Brain
Staining and Labeling
Liver

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine
  • Histology

Cite this

@article{0338038761574f64b1f17a8aef0aa629,
title = "Expression of Yes-associated protein (YAP) in metastatic breast cancer",
abstract = "The purpose of this study was to investigate the expression of Yes-associated protein (YAP) in different metastatic sites in metastatic breast cancer and to determine the clinical implications of these patterns. Immunohistochemical staining was used to investigate the expression of YAP and phospho-YAP in tissue microarrays from 122 cases of metastatic breast cancer (bone metastasis = 29, brain metastasis = 38, liver metastasis = 12, and lung metastasis = 43). The expression levels of YAP and phospho-YAP differed according to the metastatic site in metastatic breast cancer. Specifically, nuclear expression of phospho-YAP was high in brain metastasis but low in lung metastasis (P = 0.010). The effects of YAP and phospho-YAP expression on clinical outcomes were investigated by univariate analysis. This analysis showed that nuclear YAP positivity (P = 0.008) and nuclear phospho-YAP positivity (P = 0.003) were both associated with shorter overall survival. In conclusion, the level of YAP expression varies according to the metastatic site in metastatic breast cancer. Moreover, high YAP expression was correlated with poor prognosis.",
author = "Kim, {Hye Min} and Jung, {Woo Hee} and Koo, {Ja Seung}",
year = "2015",
month = "1",
day = "1",
language = "English",
volume = "8",
pages = "11248--11257",
journal = "International Journal of Clinical and Experimental Pathology",
issn = "1936-2625",
publisher = "e-Century Publishing Corporation",
number = "9",

}

Expression of Yes-associated protein (YAP) in metastatic breast cancer. / Kim, Hye Min; Jung, Woo Hee; Koo, Ja Seung.

In: International Journal of Clinical and Experimental Pathology, Vol. 8, No. 9, 01.01.2015, p. 11248-11257.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Expression of Yes-associated protein (YAP) in metastatic breast cancer

AU - Kim, Hye Min

AU - Jung, Woo Hee

AU - Koo, Ja Seung

PY - 2015/1/1

Y1 - 2015/1/1

N2 - The purpose of this study was to investigate the expression of Yes-associated protein (YAP) in different metastatic sites in metastatic breast cancer and to determine the clinical implications of these patterns. Immunohistochemical staining was used to investigate the expression of YAP and phospho-YAP in tissue microarrays from 122 cases of metastatic breast cancer (bone metastasis = 29, brain metastasis = 38, liver metastasis = 12, and lung metastasis = 43). The expression levels of YAP and phospho-YAP differed according to the metastatic site in metastatic breast cancer. Specifically, nuclear expression of phospho-YAP was high in brain metastasis but low in lung metastasis (P = 0.010). The effects of YAP and phospho-YAP expression on clinical outcomes were investigated by univariate analysis. This analysis showed that nuclear YAP positivity (P = 0.008) and nuclear phospho-YAP positivity (P = 0.003) were both associated with shorter overall survival. In conclusion, the level of YAP expression varies according to the metastatic site in metastatic breast cancer. Moreover, high YAP expression was correlated with poor prognosis.

AB - The purpose of this study was to investigate the expression of Yes-associated protein (YAP) in different metastatic sites in metastatic breast cancer and to determine the clinical implications of these patterns. Immunohistochemical staining was used to investigate the expression of YAP and phospho-YAP in tissue microarrays from 122 cases of metastatic breast cancer (bone metastasis = 29, brain metastasis = 38, liver metastasis = 12, and lung metastasis = 43). The expression levels of YAP and phospho-YAP differed according to the metastatic site in metastatic breast cancer. Specifically, nuclear expression of phospho-YAP was high in brain metastasis but low in lung metastasis (P = 0.010). The effects of YAP and phospho-YAP expression on clinical outcomes were investigated by univariate analysis. This analysis showed that nuclear YAP positivity (P = 0.008) and nuclear phospho-YAP positivity (P = 0.003) were both associated with shorter overall survival. In conclusion, the level of YAP expression varies according to the metastatic site in metastatic breast cancer. Moreover, high YAP expression was correlated with poor prognosis.

UR - http://www.scopus.com/inward/record.url?scp=85013042296&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85013042296&partnerID=8YFLogxK

M3 - Article

C2 - 26617849

AN - SCOPUS:85013042296

VL - 8

SP - 11248

EP - 11257

JO - International Journal of Clinical and Experimental Pathology

JF - International Journal of Clinical and Experimental Pathology

SN - 1936-2625

IS - 9

ER -